|
|
News and Events
Publications
 |
"AST-120 (spherical carbon adsorbent) Improves Pain and Bloating in a Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Non-Constipating Irritable Bowel Syndrome (IBS)", Tack, J, EASL, 2010 |
|
"Mild Hepatic Encephalopathy (HE) Assessed by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is Highly Prevalent in Ambulatory Patients with Cirrhosis", Randolph, C, DDW 2010 |
 |
'"The Efficacy and Tolerability of AST-120 (Spherical Carbon Adsorbent) in Active Pouchitis", Shen, Bo, AJG, 2009 (in press) |
|
“A Pilot Study on the Efficacy and Tolerability of AST-120 in the Treatment of Active Pouchitis”, Shen, Bo, ACG, 2007 (Poster) |
|
“The Efficacy and Tolerability of AST-120 (Spherical Carbon Adsorbent) in Active Pouchitis”, Shen, Bo, UEGW, 2008 (Poster) |
|
“Absence of Interactions Between AST-120 (Spherical Carbon Adsorbent), a Novel Oral Adsorbent, and Concomitant Medications: Azathioprine and CiproXR®”, Willmer, Jonathan, UEGW (Poster) |
|
“Absence of Interactions Between AST-120 (Spherical Carbon Adsorbent), a Novel Oral Adsorbent, and Concomitant Medications: Azathioprine and CiproXR®”, Willmer, Jonathan, UEGW (Abstract) |
|
“Prevention of GI Absorption of Bacterial Toxins: and In Vitro Evaluation of the Potential for Prophylactic Use of a Novel Oral Adsorbent (AST-120)”, Anderson, Keith, DDW, 2008 (Abstract) |
|
“AST-120: A Novel, Engineered Carbon Microsphere Product fir Use in Chronic Inflammatory Bowel Disease and Liver Dysfunction”, Anderson, Keith, DDW, 2008 (Abstract) |
|
“AST-120 (Spherical Carbon Adsorbent): A Novel, Engineered Carbon Microsphere Product for Use in Chronic Inflammatory Bowel Disease and Liver Function”, Anderson, Keith, DDW, 2008 (Poster) |
|
“Prevention of GI Absorption of Bacterial Toxins: an In Vitro Evaluation on the Potential for Prophylactic Use of a Novel Oral Adsorbent (AST-120, Spherical Carbon Adsorbent)”, Anderson, Keith, DDW, 2008 (Poster) |
|
“A Novel Oral Adsorbent, AST-120, Specifically and Irreversibly Binds Pro-Inflammatory Mediators of the Gut In Vitro and In Vivo”, Anderson, Keith, UEGW, 2008 (Abstract) |
|
“L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure”, Ytrebø, Lars Marius, Hepatology, Vol. 50, No. 1, 2009 |
|
“L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats”, Nathan, Davies, Hepatology, Vol. 50, No. 1, 2009 |
|
